The following drug products were reviewed and acted upon by the CDPHP Pharmacy and Therapeutics Committee on June 16, 2010.
Review the full CDPHP Clinical Formulary which includes tier status, prior authorization requirements and quantity limits for select drugs.
Also see Medicare Drug Formulary and Medicare Formulary Updates.
| Drug | New Tier / Formulary Status | Previous Tier / Formulary Status |
| Aciphex tablets (rabeprazole) | E | 3, E, QL |
| Amrix capsules (cyclobenzaprine ext-rel) | 3, ST | 3 |
| Cayston inhalation solution (aztreonam) | 3, SP | New to Market |
| Crestor 40 mg tablets (rosuvastatin) | 3, ST4 | 2, P |
| Crestor 5 mg, 10 mg, 20 mg tablets (rosuvastatin) | E | 2, P |
| Dexilant capsules (dexlansoprazole delayed-rel) | E | 3, ST, QL |
| Effexor XR capsules (venlafaxine HCl ext-rel) | 3 | 2, P |
| imipramine pamoate capsules (generic for Tofranil-PM) | 1 | New to Market |
| Istodax injection (romidepsin) | Medical Benefit, PA | New to Market |
| lansoprazole delayed-rel capsules | 1, QL, ST3 | 1, QL |
| Lescol capsules (fluvastatin) | E | 3 |
| Lescol XL tablets (fluvastatin ext-rel) | E | 3 |
| Lipitor 10 mg, 20 mg, 40 mg tablets (atorvastatin) | E | 2, P |
| Lipitor 80 mg tablets (atorvastatin) | 2, ST4 | 2, P |
| Livalo tablets (pitavastatin) | E | New to Market |
| metaxalone tablets (generic for Skelaxin) | 3 | New to Market |
| Mevacor tablets (lovastatin) | E | 3 |
| Nexium capsules (esomeprazole delayed-rel) | E | 2, QL, P |
| omeprazole delayed-rel capsules 40mg | 1, P | 1, P, QL |
| Omnitrope injection (somatropin [rDNA origin]) | 3, ST2, PA, SP | 2, PA, SP |
| pantoprazole delayed-rel tablet (generic for Protonix) | 1, QL, ST3 | 1, ST, QL |
| Pravachol tablets (pravastatin) | E | 3 |
| Prevacid capsules/solutab (lansoprazole delayed-rel) | E | 3, QL |
| Prilosec capsules (omeprazole delayed-rel) | E | 3, QL |
| Qutenza transdermal patch (capsaicin) | Non-Covered Technology | New to Market |
| Revatio injection (sildenafil) | Medical Benefit, PA | New to Market |
| Vpriv injection (velaglucerase) | Medical Benefit, PA, SP | New to Market |
| Xiaflex injection (collagenase clostridium histolyticum) | Non-Covered Technology | New to Market |
| Xifaxan 550mg tablets (rifaximin) | 3 | New to Market |
| Zegerid capsules/powder for oral suspension (omeprazole/sodium bicarbonate) | E | 3, E, QL |
| Zirgan ophthalmic gel (ganciclovir) | 3 | New to Market |
| Zocor tablets (simvastatin) | E | 3 |
The drug names listed here are the registered and/or unregistered trademarks of third-party pharmaceutical companies unrelated to and unaffiliated with CDPHP. These trademarked brand names are included here for informational purposes only and are not intended to imply or suggest any affiliation between CDPHP and such third-party pharmaceutical companies.